Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Rotavirus.
  • Published Date:
    1998 Oct-Dec
  • Source:
    Emerg Infect Dis. 4(4):561-570.
Filetype[PDF-356.44 KB]


Details:
  • Alternative Title:
    Emerg Infect Dis
  • Personal Author:
  • Description:
    Rotavirus, the most common diarrheal pathogen in children worldwide, causes approximately one third of diarrhea-associated hospitalizations and 800,000 deaths per year. Because natural infection reduces the incidence and severity of subsequent episodes, rotavirus diarrhea might be controlled through vaccination. Serotypespecific immunity may play a role in protection from disease. Tetravalent rhesus-human reassortant rotavirus vaccine (RRV-TV) (which contains a rhesus rotavirus with serotype G3 specificity and reassortant rhesus-human rotaviruses with G1, G2, and G4 specificity) provides coverage against the four common serotypes of human rotavirus. In clinical trials in industrialized countries, RRV-TV conferred 49% to 68% protection against any rotavirus diarrhea and 61% to 100% protection against severe disease. This vaccine was licensed by the U.S. Food and Drug Administration on August 31, 1998, and should be cost-effective in reducing diarrheal diseases in industrialized countries. The vaccine's efficacy and cost-effectiveness in developing countries should be evaluated.

  • Subject:
  • Document Type:
    Journal Article
  • Collection(s):
    Emerging Infectious Diseases
    CDC Public Access
  • Main Document Checksum:
No Related Documents.
You May Also Like:
  1. Manual for the surveillance of vaccine-preventable diseases. Chapter 13: Rotavirus
    Personal Author:
    Payne, Daniel C.; Wikswo, Mary; Parashar, Umesh D.;
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.)
    Published Date:
    Aug 2011
    Series:
    Manual for the surveillance of vaccine-preventable diseases ; chapter 13
    Description:
    Chapter 13 of: Manual for the surveillance of vaccine-preventable diseases. 5th edition, 2011.Rotavirus is the most common cause of severe gastroenteritis in infants and young children worldwide. Nearly every US child who is not vaccinated against ro...
    File Type:
    Filetype[PDF - 805.13 KB]
  2. Association between mixed rotavirus vaccination types of infants and rotavirus acute gastroenteritis
    Personal Author:
    Mohammed, Anaam; Immergluck, Lilly; Parker, Trisha Chan; Jain, Shabnam; Leong, Traci; Anderson, Evan J.; Jerris, Robert C.;
    Published Date:
    Aug 29 2015
    Source:
    Vaccine. 33(42):5670-5677.
    Description:
    IntroductionRotavirus remains the leading cause of severe diarrhea in children under 5 years worldwide. In the US, Rotarix® (RV1) and RotaTeq® (RV5), have been associated with reductions in and severity of rotavirus disease. Studies have evaluated ...
    File Type:
    Filetype[PDF - 512.14 KB]
  3. Trends in the Laboratory Detection of Rotavirus Before and After Implementation of Routine Rotavirus Vaccination — United States, 2000–2018
    Personal Author:
    Hallowell, Benjamin D.; Parashar, Umesh D.; Curns, Aaron; DeGroote, Nicholas P.; Tate, Jacqueline E.;
    Published Date:
    June 21 2019
    Source:
    MMWR Morb Mortal Wkly Rep. 68(24):539-543
    Description:
    Before the introduction of rotavirus vaccine in the United States in 2006, rotavirus infection was the leading cause of severe gastroenteritis among U.S. children (1). To evaluate the long-term impact of rotavirus vaccination on disease prevalence an...
    File Type:
    Filetype[PDF - 147.55 KB]
  4. Rotavirus vaccine for the prevention of rotavirus gastroenteritis among children : recommendations of the Advisory Committee on Immunization Practices (ACIP)
    Personal Author:
    Bresee, Joseph S.; Glass, Roger I.; Vitek, Charles R.;
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.. National Center for Infectious Diseases (U.S.). Division of Viral and Rickettsial Diseases.. National Immunization Program (Centers for Disease Control and Prevention). Epidemiology and Surveillance Division..
    Published Date:
    March 19, 1999
    Source:
    MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports / Centers for Disease Control. 1999; 48(RR-2):1-20.
    Series:
    MMWR. Morbidity and mortality weekly report. Recommendations and reports ; v. 48, RR-2
    Description:
    These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of an oral, live rotavirus vaccine licensed by the Food and Drug Administration on August 31, 1998, for use among infants. This ...
    Status:
    superseded
    File Type:
    Filetype[PDF - 432.05 KB]
  5. Impact of pentavalent rotavirus vaccine against severe rotavirus diarrhoea in The Gambia
    Personal Author:
    Sanneh, Bakary; Sey, Alhagie Papa; Shah, Minesh; Tate, Jacqueline; Sonko, Mariama; Jagne, Sheriffo; Jarju, ModouLamin; Sowe, Dawda; Taal, Makie; Cohen, Adam; Parashar, Umesh; Mwenda, Jason M.;
    Published Date:
    March 12 2018
    Source:
    Vaccine. 36(47):7179-7184
    Description:
    Introduction:Rotavirus vaccines protect against the leading cause of severe childhood diarrhoea, and have been introduced in many low-income African countries. The Gambia introduced Rotateq® (RV5) into their national immunization program in 2013. We...
    File Type:
    Filetype[PDF - 678.12 KB]